<ul><li>The French government is to take a stake in Sanofi's consumer healthcare division to quell backlash over the sale to US firm CD&R.</li><li>Sanofi is spinning off Opella, which produces popular brands such as Doliprane and Dulcolax.</li><li>France's state-owned investment bank, Bpifrance, will take a 2% stake in Opella if the deal goes through.</li><li>The move aims to ensure French jobs and maintain control over Opella's operations.</li></ul>

France to take stake in Sanofi unit to quell backlash over sale to US firm

Discover more